新型主动脉内经皮机械循环支持装置的长期安全性与耐久性
研究评估Aortix泵(一种经皮部署的主动脉内泵)用于非终末期心衰患者长期门诊使用的安全性与耐久性。在4只未拴系绵羊中植入泵,运行90至142天后择期停止。泵轴承组件仅见表面磨损,无临床显著溶血,主动脉和肾脏组织病理学未见装置相关发现或粘连,提示Aortix适合长期(>6个月)门诊使用。
要点
- Aortix泵在4只绵羊中运行90至142天,择期停止。
- 泵轴承组件仅见表面磨损,无临床显著溶血。
- 主动脉和肾脏组织病理学未见装置相关发现或粘连,提示适合长期门诊使用。
核心结论
- Aortix泵在绵羊体内运行90至142天,轴承仅表面磨损,无临床显著溶血,组织病理学无装置相关发现,提示其适合长期(>6个月)门诊使用。
研究设计与样本
- 在4只未拴系绵羊中植入Aortix泵,运行90至142天后择期停止,评估长期门诊使用的安全性与耐久性。
主要发现
- 泵运行90至142天,择期停止。
- 泵轴承组件仅见表面磨损。
- 未观察到临床显著溶血。
- 主动脉和肾脏组织病理学未见装置相关发现或粘连。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
An unmet need exists for minimally invasive percutaneous mechanical circulatory support (pMCS) devices to provide partial support and promote cardiac rest and recovery in non-end-stage heart failure patients. This indication requires safe, long-term, ambulatory use with standard anticoagulation. The Aortix pump (Procyrion, Houston, Texas, USA) is a percutaneously deployed intra-aortic pump currently being clinically evaluated for subacute use and has the potential to provide extended therapy for non-end-stage heart failure patients. The device has demonstrated hemocompatibility and hemodynamic impact and has features well suited for home use. To evaluate the Aortix pump for long-term, ambulatory use, pumps were implanted in 4 untethered sheep. Pumps operated for 90 to 142 days and were stopped electively. Pump bearing components were found to have only superficial wear. No clinically significant hemolysis was observed and aorta and kidney histopathology showed no device-related findings or adhesions, suggesting Aortix is suitable for long-term (>6 months) ambulatory use.
引用
- Lu C, Krisher J, Benavides O, et al. Long-term safety and durability of novel intra-aortic percutaneous mechanical circulatory support device. J Heart Lung Transplant. 2022. PMID: 36435579. doi:10.1016/j.healun.2022.10.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。